Dr. Nandini Shankara Narayana

OP Timing:

Qualifications & Education:

• PhD (Andrology) – University of Sydney
• FRACP – Internal Medicine & Endocrinology (Australia)
• MBBS – Bangalore Medical College & Research Institute

Areas of Expertise:

• Diabetes & Endocrinology
  • Type 1 & Type 2 Diabetes
  • Complex chronic metabolic disease management
  • Gestational diabetes
  • Weight management, obesity & metabolic disorders
  • Diabetes technology (CGM, insulin pumps)
• Thyroid, Pituitary & Adrenal Disorders
• Bone & Calcium Metabolism
  • Osteoporosis
  • Hyperparathyroidism
• Female Reproductive Endocrinology
  • PCOS
  • Menopausal hormone replacement
• Transgender Care
• Male Reproductive Endocrinology / Andrology
  • Male hypogonadism
  • Infertility & testosterone therapy
  • Fertility preservation
  • Pubertal induction
  • Disorders of sexual differentiation
  • Genetic hypogonadism

Professional Experience:

Dr. Nandini Shankara Narayana is an endocrinologist and andrologist with extensive international experience across India, the UK, and Australia. After securing a Gold Medal from Bangalore Medical College in 2003, she continued advanced medical training in the UK and Australia.

• Consultant Endocrinologist & Andrologist – Concord Repatriation General Hospital, Sydney, Australia
• Endocrinology & Andrology Advanced Training – Royal Prince Alfred Hospital; Royal North Shore Hospital; Westmead Hospital, Sydney
• Basic Physician Training – Westmead, Blacktown & Hornsby Hospitals, Sydney
• RMO & Junior Doctor roles – UK and India

Key Achievements & Honours:

• Invited Plenary Speaker – ESA Clinical Weekend (2021)
• Paul Lee Best Abstract Award – ESA (2020)
• ESA Young Investigator Award – (2019)
• Gargi Award – Science & Research, Hindu Council of Australia (2020)
• Ferring Innovation & Clinical Excellence Award (2019)
• Publications in JCEM, Human Reproduction, Andrology, EJE and other high-impact journals
• JCEM article listed among top 10% most cited (2019–2020)
• Featured in media for androgen abuse recovery research (US Endo 2019)

Research & Publications:

Dr. Nandini has authored and co-authored numerous high-impact international publications. Key works include:

• Successful colonization of the testicular germinal epithelium by bone marrow stem cells producing spermatozoa of donor genotype is rare. Andrology Nov 2024
• Long-term Self-reported Outcomes Of Randomized Testosterone (T) vs Placebo (P) Treatment In The T4DM Study. Journal of the Endocrine Society
• Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study. J Clin Endocrinol Metab. 2023 
• Reliability of Drug History to Verify Androgen Abuse in Men. J Clin Endocrinol Metab. 2022 
• Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections. Eur J Endocrinol. 2022 
• Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender men. Endocr Connect. 2021
• Androgen replacement in men. Maximising efficacy, minimising adverse effects. Endocrinology Today 2021
• Rate and Extent of Recovery from Reproductive and Cardiac Dysfunction Due to Androgen Abuse in Men. The Journal of Clinical Endocrinology & Metabolism
• Androgen Abuse is Associated With Reversible, HDL-dependent Suppression of Cholesterol Efflux Capacity Circulation 2019;140:A10985
• Sperm cryopreservation prior to gonadotoxic treatment: experience of a single academic centre over 4 decades. Human Reproduction, 34(5), 795-803.
• Painful Ovulation in a 46, XX SRY-ve Adult Male due to SOX9 Duplication: Case Report and Literature Review-   Endocrinology, Diabetes & Metabolism Case Reports, 2017
• A duplication in a patient with 46, XX ovo-testicular Disorder of Sex Development refines the SOX9 testis–specific regulatory region to 24 kb Clinical Genetics 2017
• Investigation of thyroid nodules Endocrinology Today 2017
• Accuracy of a Direct Progesterone Immunoassay - The Journal of Applied Laboratory Medicine: 2016
• Markedly elevated serum thyroglobulin associated with heterophile antibodies: a cautionary tale.  Thyroid, June 2013

Conferences & Scientific Presentations:

• Endocrine Society of Australia (ESA) – Plenary Speaker
• Endocrine Society (USA)
• American Heart Association Scientific Sessions
• ESA–SRB–AOTA Annual Congress
• Multiple national & international endocrine meetings

Teaching Experience:

• Senior Clinical Lecturer – University of Sydney and Sydney Medical School
• Teaching Fellow in Medicine – United Kingdom
• Mentor for endocrinology trainees (MD, DM, MPhil, PhD), medical students & junior doctors
• Coordinator – Postgraduate Metabolic Health Program, University of Sydney
• Faculty for endocrine academic and clinical training

Registrations & Memberships:

• Royal Australian College of Physicians
• AHPRA – Australia
• General Medical Council – UK (Past)
• Karnataka Medical Council – India
• Endocrine Society of Australia
• Endocrine Society (USA)
• Australian Diabetes Association (Past)
• Australian & New Zealand Bone and Mineral Society (Past)

Languages Known:

English, Kannada, and Hindi